Name: Latest research reports of Divi's Laboratories Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Divi's Laboratories Ltd.
Rating: 3
Author: Motilal Oswal

Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Star

6888.5000 -18.00 (-0.26%)

NSE Jul 07, 2025 15:31 PM

New 52W High in past week

Volume: 85,574

Divi's Laboratories Ltd.

12 Aug 2019

6888.50

-0.26%

Adverse macro situation for raw materials impacts profitability

Neutral: Divi's Laboratories Ltd.

Motilal Oswal

Adverse macro situation for raw materials impacts profitability Motilal Oswal values your support in the Asiamoney Brokers Poll 2019 for...

Divi's Laboratories .. has an average target of 5900.88 from 8 brokers.